Ardent Health Partners Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets as of and December 31,
CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, 2024 (1) | December 31, 2023 (1) | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $563,142 | $437,577 |
| Accounts receivable | 705,747 | 775,452 |
| Inventories | 108,231 | 105,485 |
| Prepaid expenses | 119,956 | 77,281 |
| Other current assets | 193,616 | 222,290 |
| Total current assets | 1,690,692 | 1,618,085 |
| Property and equipment, net | 814,860 | 811,089 |
| Operating lease right of use assets | 261,214 | 260,003 |
| Operating lease right of use assets, related party | 932,246 | 941,150 |
| Goodwill | 852,001 | 844,704 |
| Other intangible assets, net | 76,930 | 76,930 |
| Deferred income taxes | 34,764 | 32,491 |
| Other assets | 137,307 | 147,106 |
| Total assets | $4,800,014 | $4,731,558 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Current installments of long-term debt | $12,167 | $18,605 |
| Accounts payable | 368,850 | 474,543 |
| Accrued salaries and benefits | 255,370 | 267,685 |
| Other accrued expenses and liabilities | 250,945 | 233,271 |
| Total current liabilities | 887,332 | 994,104 |
| Long-term debt, less current installments | 1,083,725 | 1,168,253 |
| Long-term operating lease liability | 233,786 | 235,241 |
| Long-term operating lease liability, related party | 922,665 | 932,090 |
| Self-insured liabilities | 231,951 | 243,552 |
| Other long-term liabilities | 53,686 | 76,002 |
| Total liabilities | 3,413,145 | 3,649,242 |
| Commitments and contingencies (see Note 9) | ||
| Redeemable noncontrolling interests | 2,391 | 7,302 |
| Equity: | ||
| Common units, no and unlimited units authorized as of September 30, 2024 and December 31, 2023, respectively; no and 484,922,828 units issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | — | 496,882 |
| Preferred stock, par value $0.01 per share; 50,000,000 and no shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | — | — |
| Common stock, par value $0.01 per share; 750,000,000 and no shares authorized as of September 30, 2024 and December 31, 2023, respectively; 142,735,842 and no shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 1,428 | — |
| Additional paid-in capital | 743,364 | — |
| Accumulated other comprehensive income | 9,486 | 18,561 |
| Retained earnings | 251,592 | 155,453 |
| Equity attributable to Ardent Health Partners, Inc. | 1,005,870 | 670,896 |
| Noncontrolling interests | 378,608 | 404,118 |
| Total equity | 1,384,478 | 1,075,014 |
| Total liabilities and equity | $4,800,014 | $4,731,558 |
(1)As of September 30, 2024 and December 31, 2023, the unaudited condensed consolidated balance sheets included total liabilities of consolidated variable interest entities of
$303.2 million and$337.8 million, respectively. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.